Taken together, the presentation is best explained by clinically amyopathic, anti-NXP2-positive dermatomyositis with extensive dystrophic calcinosis [1,14], occurring alongside and likely amplifying pre-existing large-vessel atherosclerotic disease to produce critical limb ischaemia. This evidence concerns the gene MORC3 and dermatomyositis.